<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">78055</article-id><article-id pub-id-type="doi">10.7554/eLife.78055</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Short Report</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Synaptic location is a determinant of the detrimental effects of α-Synuclein pathology to glutamatergic transmission in the basolateral amygdala</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-272267"><name><surname>Chen</surname><given-names>Liqiang</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3236-1129</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-272266"><name><surname>Nagaraja</surname><given-names>Chetan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-272268"><name><surname>Daniels</surname><given-names>Samuel</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283537"><name><surname>Fisk</surname><given-names>Zoe A</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283538"><name><surname>Dvorak</surname><given-names>Rachel</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-272269"><name><surname>Meyerdirk</surname><given-names>Lindsay</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-272270"><name><surname>Steiner</surname><given-names>Jennifer A</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0953-1310</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-272271"><name><surname>Escobar Galvis</surname><given-names>Martha L</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8400-9392</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-221192"><name><surname>Henderson</surname><given-names>Michael X</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283536"><name><surname>Rousseaux</surname><given-names>Maxime WC</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-187499"><name><surname>Brundin</surname><given-names>Patrik</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-164571"><name><surname>Chu</surname><given-names>Hong-Yuan</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0923-683X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Neurodegenerative Science</institution>, <institution>Van Andel Institute</institution>, <addr-line><named-content content-type="city">Grand Rapids</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Cellular and Molecular Medicine</institution>, <institution>University of Ottawa</institution>, <addr-line><named-content content-type="city">Ottawa</named-content></addr-line>, <country>Canada</country></aff><aff id="aff3"><institution content-type="dept">Department of Neurodegenerative Science</institution>, <institution>Van Andel Institute</institution>, <addr-line><named-content content-type="city">GRand Rapids</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Pharma Research and Early Development (pRED)</institution>, <institution>F. Hoffmann-La Roche</institution>, <addr-line><named-content content-type="city">Little Falls</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-67693"><name><surname>Ding</surname><given-names>Jun</given-names></name><role>Reviewing editor</role><aff><institution>Stanford University</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>hongyuan.chu@vai.org</email> (HC);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>01</day><month>07</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e78055</elocation-id><history><date date-type="received"><day>20</day><month>02</month><year>2022</year></date><date date-type="accepted"><day>27</day><month>06</month><year>2022</year></date></history><permissions><copyright-statement>© 2022, Chen et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Chen et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-78055-v1.pdf"/><abstract><p>The presynaptic protein α-synuclein (αSyn) has been suggested to be involved in the pathogenesis of Parkinson’s disease (PD). In PD, the amygdala is prone to develop insoluble αSyn aggregates, and it has been suggested that circuit dysfunction involving the amygdala contributes to the psychiatric symptoms. Yet, how αSyn aggregates affect amygdala function is unknown. In this study, we examined αSyn in glutamatergic axon terminals and the impact of its aggregation on glutamatergic transmission in the basolateral amygdala (BLA). We found that αSyn is primarily present in the vesicular glutamate transporter 1-expressing (vGluT1<sup>+</sup>) terminals in mouse BLA, which is consistent with higher levels of αSyn expression in vGluT1<sup>+</sup> glutamatergic neurons in the cerebral cortex relative to the vGluT2<sup>+</sup> glutamatergic neurons in the thalamus.  We found that αSyn aggregation selectively decreased the cortico-BLA, but not the thalamo-BLA, transmission; and that cortico-BLA synapses displayed enhanced short-term depression upon repetitive stimulation. In addition, using confocal microscopy, we found that vGluT1<sup>+</sup> axon terminals exhibited decreased levels of soluble αSyn, which suggests that lower levels of soluble αSyn might underlie the enhanced short-term depression of cortico-BLA synapses. In agreement with this idea, we found that cortico-BLA synaptic depression was also enhanced in αSyn knockout mice. In conclusion, both basal and dynamic cortico-BLA transmission were disrupted by abnormal aggregation of αSyn and these changes might be relevant to the perturbed cortical control of the amygdala that has been suggested to play a role in psychiatric symptoms in PD.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000874</institution-id><institution>Brain and Behavior Research Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Chu</surname><given-names>Hong-Yuan</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000090</institution-id><institution>Congressionally Directed Medical Research Programs</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Chu</surname><given-names>Hong-Yuan</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100018231</institution-id><institution>Aligning Science Across Parkinson's</institution></institution-wrap></funding-source><award-id>ASAP-020616</award-id><principal-award-recipient><name><surname>Henderson</surname><given-names>Michael X</given-names></name><name><surname>Rousseaux</surname><given-names>Maxime WC</given-names></name><name><surname>Chu</surname><given-names>Hong-Yuan</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100018231</institution-id><institution>Aligning Science Across Parkinson's</institution></institution-wrap></funding-source><award-id>ASAP-020625</award-id><principal-award-recipient><name><surname>Rousseaux</surname><given-names>Maxime WC</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100018231</institution-id><institution>Aligning Science Across Parkinson's</institution></institution-wrap></funding-source><award-id>ASAP-020572</award-id><principal-award-recipient><name><surname>Chu</surname><given-names>Hong-Yuan</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Patrik Brundin, has received support as a consultant from AbbVie, Axial Therapeutics., Calico Life Sciences, CuraSen, Enterin Inc, Fujifilm-Cellular Dynamics International, Idorsia Pharmaceuticals, Lundbeck A/S. He has received commercial support for research from Lundbeck A/S and F. Hoffman-La Roche. He has ownership interests in Acousort AB, Axial Therapeutics, Enterin Inc and RYNE Biotechnology. During the time that this paper was undergoing revision he became an employee of F. Hoffman-La Roche, although none of the data were generated by this company..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animal studies were reviewed and approved by the Institutional Animal Care and Use Committee at Van Andel Institute (animal use protocol#: 22-02-007).</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All source data associated with the revised manuscript have been deposited on Open Science Framework: https://doi.org/10.17605/OSF.IO/264SM.All data generated or analyzed during this study are included in the manuscript and source data have been provided for all main and supplementary figures.</p></sec><supplementary-material><ext-link xlink:href="elife-78055-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>